Aldehyde dehydrogenase 1A1 in stem cells and cancer.

Tomita H, Tanaka K, Tanaka T, Hara A. · 2016

Read Aldehyde dehydrogenase 1A1 in stem cells and cancer. by Tomita H, Tanaka K, Tanaka T, Hara A. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4905455.txt.

Description

Hiroshi Tomita and co-authors reviewed the enzyme ALDH1A1 in stem cells and cancer in 2016. The human genome holds 19 working aldehyde dehydrogenase genes, which detoxify harmful aldehydes. One branch, ALDH1, marks normal tissue stem cells and cancer stem cells alike, aiding self-renewal and self-protection. Its activity rests mostly on the 1A1 form, in a tissue-specific way.

High activity and excess 1A1 often track with poor cancer outlook, though not in every tumor type. In tissues that normally run low on 1A1, such as breast, lung, and colon, the enzyme makes a clean drug target on cancer stem cells. The review weighs where blocking it could kill the cells that regrow tumors.

Catalog record

CREATORTomita H, Tanaka K, Tanaka T, Hara A.
YEAR2016
COLLECTIONPAPERS
FORMATTXT
FILE SIZE58 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4905455

Browse the full library · About the Tower of Babel